68193
L-3-苯基乳酸甲酯
≥97.0% (HPLC)
别名:
(S)-2-羟基-3-苯基丙酸甲酯
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C10H12O3
化学文摘社编号:
分子量:
180.20
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352108
MDL number:
产品名称
L-3-苯基乳酸甲酯, ≥97.0% (HPLC)
InChI key
NMPPJJIBQQCOOI-VIFPVBQESA-N
SMILES string
COC(=O)[C@@H](O)Cc1ccccc1
InChI
1S/C10H12O3/c1-13-10(12)9(11)7-8-5-3-2-4-6-8/h2-6,9,11H,7H2,1H3/t9-/m0/s1
assay
≥97.0% (HPLC)
optical activity
[α]/D +4.4±0.5°, c = 1% in methanol
mp
40-45 °C (lit.)
functional group
ester
hydroxyl
phenyl
正在寻找类似产品? 访问 产品对比指南
Application
Methyl L-3-phenyllactate can be used:
- As an intermediate in the synthesis of bortezomib analogs as 20S proteasome inhibitors.
- As a substrate in the amination of the benzylic C-H bonds and the aminated products are further used to prepare β-lactams.
- As an intermediate in one of the key synthetic steps for the preparation of YM-254890 analog, a selective Gαq/11 inhibitor.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Toward the selective inhibition of G proteins: total synthesis of a simplified YM-254890 analog
Rensing DT, et al.
Organic Letters, 17(9), 2270-2273 (2015)
Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib
Xu Y, et al.
Bioorganic & Medicinal Chemistry Letters, 28(12), 2148-2152 (2018)
Synthesis of Biologically Relevant Compounds by Ruthenium Porphyrin Catalyzed Amination of Benzylic C-H Bonds
Zardi P, et al.
Organometallics, 33(9), 2210-2218 (2014)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持